Abivax(AAVXF)

Focus: Abivax is a publicly traded French biotechnology company focused on viral diseases and immunology, operating as a clinical-stage biotech with a diversified pipeline across infectious diseases and oncology indications.

Immunology Infectious Diseases Oncology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Funding Stage

PUBLIC

Open Jobs

About Abivax

AI assessmentNot Hiring

No open roles listed right now. Follow Abivax to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthStrong

Pipeline

Late-stage

4 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

ABX464

Healthy Volunteers

Phase 1

Clinical Trials (1)

NCT05032560Safety and Pharmacokinetics Study in Healthy Japanese Volunteers

Phase 1

Help build intelligence for Abivax

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Lead a Phase 3 program (obefazimod for ulcerative colitis) with 19 active trials, offering exposure to late-stage clinical development and potential near-term value creation
Work across multiple therapeutic modalities spanning immunology, infectious diseases, and oncology with 20 total active trials providing diverse scientific learning opportunities
Join a European public biotech with headquarters in Montpellier, offering a location advantage for EU-based professionals seeking biotech career growth

Watch Out For

Zero current job openings listed despite being a publicly traded company suggests limited hiring momentum or potential organizational constraint
No disclosed financial data (revenue, R&D spend, cash position) raises transparency concerns about company health and runway visibility for long-term stability

Generated by Claude from Abivax's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Caffeine

Healthy

Phase 1

Clinical Trials (1)

NCT05121714Evaluation of the Potential CYP1A2-mediated Drug Drug Interaction Safety, and Tolerability of ABX464

Phase 1

ABX464 Single dose

Healthy Volunteers

Phase 1

Clinical Trials (1)

NCT02731885Food Effect on Pharmacokinetic Parameters of ABX464

Phase 1